
Investments
234Portfolio Exits
73Funds
15Partners & Customers
3About EW Healthcare Partners
EW Healthcare Partners is a venture capital firm pursuing investments in pharmaceuticals, biotechnology, medical devices, health care services and health information technology. EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been involved in the founding, investing, and/or management of healthcare companies ranging across all sectors, stages and geography.

Want to inform investors similar to EW Healthcare Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest EW Healthcare Partners News
Aug 3, 2023
VitalConnect – a leader in remote and in-hospital wearable biosensor technology – recently announced the closing on an oversubscribed Series F financing in excess of $30 million. The funding round was led by Revelation Partners, with significant participation from the company’s existing investors, including Pacific General Ventures and EW Healthcare Partners. The additional funding round will support VitalConnect’s rapidly growing remote cardiac monitoring business while advancing key partnerships with the largest hospital systems in the United States to provide remote patient monitoring in an in-patient setting. Launched in 2011, VitalConnect has deployed hundreds of thousands of biosensors throughout the world, including leading healthcare facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. And the VitalPatch enables real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients. KEY QUOTES: “VitalConnect’s services have been widely adopted at an accelerated pace over the past 24 months, enabling our revenue to triple from 2021 to 2022, and putting us on track to nearly double revenue again in 2023. We are also experiencing significant EBITDA improvement and we expect to achieve profitability in 2024. This latest round of financing, at an increased valuation, signals unwavering support from our investors while providing the company the runway needed to achieve our goal of being the world’s leading provider of remote patient monitoring solutions.” — Peter Van Haur, CEO of VitalConnect “Revelation Partners is excited to join the distinguished list of VitalConnect investors to help further accelerate the company’s already impressive growth. VitalConnect is in the unique position of being able to meaningfully participate in multiple billion-dollar markets that are growing at double-digit rates. The adoption of the technology in the marketplace, thus far, has been unprecedented, thereby giving us confidence in the leadership team’s ability to execute. We are committed to supporting the organization to enable them to maximize both revenue and profitability.” — Fred Lee, Partner at Revelation Partners Trending on Pulse 2.0
EW Healthcare Partners Investments
234 Investments
EW Healthcare Partners has made 234 investments. Their latest investment was in VitalConnect as part of their Series F on July 7, 2023.

EW Healthcare Partners Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
7/18/2023 | Series F | VitalConnect | $30M | No | 7 | |
1/7/2022 | Series E | VitalConnect | $39M | Yes | EW Healthcare Partners, MVM Partners, and Undisclosed Investors | 10 |
11/18/2020 | Series D | COTA | $34M | Yes | Baptist Health South Florida, Boston Millennia Partners, dRx Capital, EW Healthcare Partners, Horizon Blue Cross Blue Shield of New Jersey, ONC Capital, and Undisclosed Investors | 6 |
9/11/2020 | Series F | |||||
7/14/2020 | Series H |
Date | 7/18/2023 | 1/7/2022 | 11/18/2020 | 9/11/2020 | 7/14/2020 |
---|---|---|---|---|---|
Round | Series F | Series E | Series D | Series F | Series H |
Company | VitalConnect | VitalConnect | COTA | ||
Amount | $30M | $39M | $34M | ||
New? | No | Yes | Yes | ||
Co-Investors | EW Healthcare Partners, MVM Partners, and Undisclosed Investors | Baptist Health South Florida, Boston Millennia Partners, dRx Capital, EW Healthcare Partners, Horizon Blue Cross Blue Shield of New Jersey, ONC Capital, and Undisclosed Investors | |||
Sources | 7 | 10 | 6 |
EW Healthcare Partners Portfolio Exits
73 Portfolio Exits
EW Healthcare Partners has 73 portfolio exits. Their latest portfolio exit was Abiomed on December 22, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
12/22/2022 | Acq - P2P | 5 | |||
12/21/2021 | Acquired | 1 | |||
10/29/2021 | IPO | Public | 4 | ||
Date | 12/22/2022 | 12/21/2021 | 10/29/2021 | ||
---|---|---|---|---|---|
Exit | Acq - P2P | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 5 | 1 | 4 |
EW Healthcare Partners Acquisitions
12 Acquisitions
EW Healthcare Partners acquired 12 companies. Their latest acquisition was Enercon Technologies on May 18, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
5/18/2023 | Acq - Fin | 1 | ||||
10/18/2022 | Acquired | 1 | ||||
5/5/2022 | Grant | $2.37M | Acq - Fin | 2 | ||
4/30/2021 | ||||||
5/10/2012 | Debt |
Date | 5/18/2023 | 10/18/2022 | 5/5/2022 | 4/30/2021 | 5/10/2012 |
---|---|---|---|---|---|
Investment Stage | Grant | Debt | |||
Companies | |||||
Valuation | |||||
Total Funding | $2.37M | ||||
Note | Acq - Fin | Acquired | Acq - Fin | ||
Sources | 1 | 1 | 2 |
EW Healthcare Partners Fund History
15 Fund Histories
EW Healthcare Partners has 15 funds, including EW Healthcare Partners Fund 2a.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
8/22/2019 | EW Healthcare Partners Fund 2a | Multi-Stage Venture Capital | Closed | $746.33M | 4 |
6/11/2019 | Titan Co-Investment Fund 2 | $27M | 1 | ||
10/28/2016 | Essex Woodlands Fund IX | Industry Focused | Closed | $543.1M | 3 |
3/30/2009 | Essex Woodlands Health Ventures VIII LP (consolidated) | ||||
5/18/2006 | Essex Woodlands Health Ventures VII LP |
Closing Date | 8/22/2019 | 6/11/2019 | 10/28/2016 | 3/30/2009 | 5/18/2006 |
---|---|---|---|---|---|
Fund | EW Healthcare Partners Fund 2a | Titan Co-Investment Fund 2 | Essex Woodlands Fund IX | Essex Woodlands Health Ventures VIII LP (consolidated) | Essex Woodlands Health Ventures VII LP |
Fund Type | Multi-Stage Venture Capital | Industry Focused | |||
Status | Closed | Closed | |||
Amount | $746.33M | $27M | $543.1M | ||
Sources | 4 | 1 | 3 |
EW Healthcare Partners Partners & Customers
3 Partners and customers
EW Healthcare Partners has 3 strategic partners and customers. EW Healthcare Partners recently partnered with Smith & Nephew on January 1, 2012.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
1/4/2012 | Partner | United Kingdom | Pantheon Ventures , a Limited Partner of Essex Woodlands , and Spindletop Healthcare Capital may participate alongside Essex Woodlands in the investment . | 5 | |
1/4/2012 | Partner | ||||
1/4/2012 | Partner |
Date | 1/4/2012 | 1/4/2012 | 1/4/2012 |
---|---|---|---|
Type | Partner | Partner | Partner |
Business Partner | |||
Country | United Kingdom | ||
News Snippet | Pantheon Ventures , a Limited Partner of Essex Woodlands , and Spindletop Healthcare Capital may participate alongside Essex Woodlands in the investment . | ||
Sources | 5 |
EW Healthcare Partners Team
21 Team Members
EW Healthcare Partners has 21 team members, including , .
Name | Work History | Title | Status |
---|---|---|---|
Marty Sutter | Founder | Current | |
Name | Marty Sutter | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Founder | ||||
Status | Current |